These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 21909406

  • 1. Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis.
    Yang XY, Chen QF, Li YP, Wu SM.
    PLoS One; 2011; 6(9):e23826. PubMed ID: 21909406
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY, Hsieh WY.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):1960-1971. PubMed ID: 28604170
    [Abstract] [Full Text] [Related]

  • 3. Adjunctive therapy with V-5 Immunitor (V5) for the treatment of tuberculosis patients: a meta-analysis.
    Feng M, Ding Q, Zhong C, Li J, Wang Q, Yuan Z, Dong Y.
    Pharmazie; 2016 Sep 01; 71(9):499-503. PubMed ID: 29441844
    [Abstract] [Full Text] [Related]

  • 4. Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis.
    Yang XY, Chen QF, Cui XH, Yu Y, Li YP.
    J Infect; 2010 May 01; 60(5):320-30. PubMed ID: 20156481
    [Abstract] [Full Text] [Related]

  • 5. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC, Abdulmumini T, Robinson S, Rook GA, Stanford JL.
    Respir Med; 1995 Mar 01; 89(3):199-207. PubMed ID: 7746913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB.
    Dlugovitzky D, Stanford C, Stanford J.
    Immunotherapy; 2011 Apr 01; 3(4):557-68. PubMed ID: 21463195
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
    Dlugovitzky D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J.
    Respir Med; 2006 Jun 01; 100(6):1079-87. PubMed ID: 16278080
    [Abstract] [Full Text] [Related]

  • 10. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): A systematic review of randomised clinical trials.
    Wang M, Guan X, Chi Y, Robinson N, Liu JP.
    Tuberculosis (Edinb); 2015 Jul 01; 95(4):364-72. PubMed ID: 25861717
    [Abstract] [Full Text] [Related]

  • 11. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
    Efremenko YV, Butov DA, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS.
    Hum Vaccin Immunother; 2013 Sep 01; 9(9):1852-6. PubMed ID: 23782489
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul 10; 354(9173):116-9. PubMed ID: 10408487
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials.
    Zhang J, Chen C, Yang J.
    Chin Med J (Engl); 2019 Dec 20; 132(24):2950-2959. PubMed ID: 31833904
    [Abstract] [Full Text] [Related]

  • 14. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97.
    Mayo RE, Stanford JL.
    Trans R Soc Trop Med Hyg; 2000 Dec 20; 94(5):563-8. PubMed ID: 11132390
    [Abstract] [Full Text] [Related]

  • 15. Adjunctive therapy of Mycobacterium vaccae vaccine in the treatment of multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    Weng H, Huang JY, Meng XY, Li S, Zhang GQ.
    Biomed Rep; 2016 May 20; 4(5):595-600. PubMed ID: 27123253
    [Abstract] [Full Text] [Related]

  • 16. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
    Luo Y, National Cooperation Group On Clinical Study Of Mycobacterium Vaccae Vaccine.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan 20; 24(1):43-7. PubMed ID: 11802939
    [Abstract] [Full Text] [Related]

  • 17. Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis.
    Johnson JL, Nunn AJ, Fourie PB, Ormerod LP, Mugerwa RD, Mwinga A, Chintu C, Ngwira B, Onyebujoh P, Zumla A.
    Int J Tuberc Lung Dis; 2004 Nov 20; 8(11):1348-54. PubMed ID: 15581204
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
    Stanford J, Stanford C, Grange J.
    Front Biosci; 2004 May 01; 9():1701-19. PubMed ID: 14977580
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de B, Garner P.
    Cochrane Database Syst Rev; 2001 May 01; (1):CD001166. PubMed ID: 11279709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.